Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Women With Adenomyosis-related Abnormal Uterine Bleeding Eligible for Hysterectomy: a Non-inferiority Randomized Clinical Trial Comparing Each Intervention to Hysterectomy
The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years
• Premenopausal women aged 30 to 50 years
• Women who had at least 3 prior months failed medical therapy, or a contraindication to medical therapy, or refused medical therapy for adenomyosis-related AUB
• Symptomatic pure internal adenomyosis or dominant adenomyosis (with less than 5 concurrent uterine fibroids type 3-7 \< 5 cm) confirmed by MRI (\< 6 months) according to ESHRE criteria
• AUB defined as a PBAC score \>100 at baseline
• Uterine ultrasound measurement of 6.0-12.0 cm (external os to internal fundus)
• Women with an indication for hysterectomy for adenomyosis-related AUB and accepting hysterectomy
• Highly effective contraception for women of childbearing potential, maintained until the onset of menopause
• Affiliated or beneficiary of health insurance
• Signed informed consent